creating hope JUNE 2012
Know the code
Genetics program offers new insights into screening for and treating cancer BY JAKE POINIER
T
he Human Genome Project was completed in 2003, but The University of Texas MD Anderson Cancer Center in Houston had begun integrating genetics into care plans for cancer patients in the mid 1990s, when two breast cancer genes, BRCA1 and BRCA2, were discovered. With other cancer genes subsequently identified, the understanding of the relationship between cancer and our genetic code has continued to progress—with implications for screenings as well as treatment. The longstanding work in genetics in Houston is now benefitting patients in Arizona at Banner MD Anderson Cancer Center. “There are primarily two populations of patients we see in our clinic,” said April O’Connor, a certified genetic counselor and the genetics program coordinator of the Banner MD Anderson Clinical Cancer Genetics Program in Gilbert. “Those who currently have cancer, and those who are healthy but concerned about their cancer risk.” The clinic’s goal is to determine whether there is a hereditary predisposition to a patient’s cancer—which occurs in about 5 to 10 percent of cases—or if it is sporadic. The distinction is critical: Hereditary cancers may react differently to treatment, and be
April O’Connor is a genetic counselor in the Clinical Cancer Genetics Program at Banner MD Anderson Cancer Center. She works with people to identify if they have a hereditary predisposition to a specific type of cancer.
INSIDE 3 Breast cancer prevention aided by cutting-
edge technology 4 Comprehensive Breast Cancer Program 5 Ask the expert - Melanoma
6 ‘Cancer has met its match’ 7 Boys susceptible to HPV 8 Events and classes